Article
The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.
The Journal of clinical investigation - 1 Jan 2003
Viollet Benoit, Andreelli Fabrizio, Jørgensen Sebastian B, Perrin Christophe, Geloen Alain, Flamez Daisy, Mu James, Lenzner Claudia, Baud Olivier, Bennoun Myriam, Gomas Emmanuel, Nicolas Gaël, Wojtaszewski Jørgen F P, Kahn Axel, Carling David, Schuit Frans C, Birnbaum Morris J, Richter Erik A, Burcelin Rémy, Vaulont Sophie
Abstract excerpt
AMP-activated protein kinase (AMPK) is viewed as a fuel sensor for glucose and lipid metabolism. To better understand the physiological role of AMPK, we generated a knockout mouse model in which the AMPKalpha2 catalytic subunit gene was inactivated. AMPKalpha2(-/-) mice presented high glucose levels in the fed period and during an oral glucose challenge associated with low insulin plasma levels. However, in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
